Payne Capital LLC Novartis Ag Transaction History
Payne Capital LLC
- $98.6 Billion
- Q3 2025
A detailed history of Payne Capital LLC transactions in Novartis Ag stock. As of the latest transaction made, Payne Capital LLC holds 5,000 shares of NVS stock, worth $625,050. This represents 0.65% of its overall portfolio holdings.
Number of Shares
5,000Holding current value
$625,050% of portfolio
0.65%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,590Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.33 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.3 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.13 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$945 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$890 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $269B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...